Angelalign Technology Reports Strong First Half Results for 2025 Amid Increased Investments
Angelalign Technology Reports Strong First Half Results for 2025 Amid Increased Investments
SAN CLEMENTE, California, August 26, 2025 – Angelalign Technology Inc. (stock code: 6699.HK) has announced impressive provisional results for the first half of 2025, showing a year-on-year revenue growth of 33.1%, reaching $161.4 million. The company’s gross profit stood at $100.6 million, with an adjusted net profit of $19.5 million. This performance comes as Angelalign enhances its investments in key areas, including legal frameworks, supply chain management, and data security.
Strong Performance with Increased Case Volume
In the first half of 2025, the global volume of transparent aligners cases surged by 47.7% compared to last year, totaling approximately 225,800 cases. This growth in case volume, paired with operational efficiency in treatment planning centers and manufacturing plants, significantly boosted their revenue, gross profit, and operational profit.
The company’s profitability during this reporting period was further bolstered by stringent expense management in anticipation of fluctuating tariff environments. This strategy included delaying the hiring of sales and marketing staff, clinical support, and customer service, along with pausing operations at some treatment planning centers and manufacturing plants outside of mainland China.
Investment in Sustainable International Presence
Angelalign is strategically increasing its long-term investments in various sectors to build a more sustainable international presence. The company plans to ramp up investment in sales and marketing, clinical support, and customer service, as well as establish and operate treatment planning centers and manufacturing facilities outside of China. They aim to continuously strengthen their legal capabilities to support and ensure compliance with intellectual property regulations while enhancing their data security infrastructure.
In markets outside of mainland China, Angelalign has seen a staggering 103.5% year-on-year increase in case volume, totaling 117,200 cases. This growth reflects both a low comparative base from the previous year and early success in new markets. The company has expanded its reach by offering high-quality treatment planning, dependable delivery systems, and continuous training programs in collaboration with key opinion leaders.
In contrast, within mainland China, Angelalign experienced a 14% increase in cases, reaching about 108,600. The firm has implemented a forward-looking growth strategy, prioritizing early orthodontic treatment and emerging market opportunities as key drivers of sustainable growth.
Introduction of Innovative Products and Solutions
During the first half of 2025, Angelalign introduced innovative products and solutions focusing on early orthodontic treatment and complex cases, including smart initial consultations and treatment monitoring tools. Collaboration with several universities has enabled the development of significant clinical innovations.
The company remains resolute in its intellectual property strategy and regulatory compliance, which are fundamental priorities. As Angelalign continues to expand globally, substantial investments will be made to bolster legal capabilities. The firm is committed to maintaining its trajectory of product innovation while firmly defending its intellectual property rights.
Development of a Cutting-Edge Manufacturing System
To meet the increasing market demand, Angelalign is developing a state-of-the-art smart manufacturing system that puts user care, environmental sustainability, and scalability at the forefront. The company plans to establish or expand manufacturing and treatment planning facilities in key global locations to ensure timely and stable product and service delivery to customers worldwide. Currently, treatment planning centers in Brazil and Southeast Asia provide services that extend to the United States.
Focused on Data Security and Operational Compliance
Additionally, significant resources have been dedicated to modernizing data security infrastructure and operational processes to ensure compliance with data security and privacy regulations across all major markets. This represents a considerable ongoing investment that will continue to be a priority.
Fox Hu, CEO of Angel, stated, “We remain confident in the long-term growth prospects of the global transparent aligner industry. Our key priorities include increasing the production of aligners and treatment plans, enhancing clinical capabilities, continuing our product innovation trajectory with the appropriate intellectual property protections, raising our compliance investment, and driving sustainable growth across all regions.”
Conclusion
Founded in 2003, Angelalign Technology Inc. has served 1.5 million smiles, providing digital technology-based transparent aligners products and services to meet the needs of dental professionals and patients globally. The company's innovative products and technical services have established it as a prominent player in the orthodontic industry. Angelalign officially listed on the Hong Kong Stock Exchange in 2021 and has embarked on a global expansion strategy in 2023, with its products and services now available in over 50 countries and regions. For more information, visit angelaligner.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.